Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism.

The Journal of cell biology 2026
Open on PubMed

A pathological hallmark in >97% of amyotrophic lateral sclerosis (ALS) cases is the cytoplasmic mislocalization and aggregation of TDP-43, a nuclear RNA-binding protein, in motor neurons. Driving clearance of cytoplasmic TDP-43 reduces toxicity in ALS models, though how TDP-43 clearance is regulated remains controversial. We conducted an unbiased yeast screen using high-throughput dot blotting to identify genes that affect TDP-43 levels. We identified ESCRT complex genes, which induce membrane invagination (particularly at multivesicular bodies; MVBs) and genes linked to K63 ubiquitination (particularly cofactors of the E3 ubiquitin ligase Rsp5; NEDD4 in humans), as drivers of TDP-43 endolysosomal clearance. TDP-43 colocalized and bound Rsp5/NEDD4 and ESCRT proteins, and perturbations to either increased TDP-43 aggregation, stability, and toxicity. NEDD4 also ubiquitinates TDP-43. Lastly, TDP-43 accumulation induces giant MVB-like vesicles, within which TDP-43 accumulates in a NEDD4-dependent manner. Our studies shed light on endolysosomal-mediated cytoplasmic protein clearance, a poorly understood proteostasis mechanism, which may help identify novel ALS therapeutic strategies.

14 Figures Extracted
Figure 1.
Figure 1. PMC
A dot-blot genetic screen in yeast identifies genes regulating TDP-43 steady-state levels. (A) Schematic representation of the dot-blot genetic scree...
Figure 2.
Figure 2. PMC
TDP-43 clearance and aggregation depend on ESCRT function. (A) Indicated strains were transformed with TDP-43-mRuby2 plasmid (pRB194) and grown to mi...
Figure 3.
Figure 3. PMC
TDP-43 toxicity, aggregation, and toxicity depend on the E3 ubiquitin ligase Rsp5. (A) Representative serial dilution growth assay of WT and rsp5-3 ...
Figure S1.
Figure S1. PMC
Knockout of the Rsp5 adaptor Rim8 increases TDP-43-YFP levels. Indicated strains were transformed with TDP-43-YFP plasmid (pRB109) and grown to mid-l...
Figure 4.
Figure 4. PMC
VPS4A E228Q increases TDP-43 stability and promotes cytoplasmic mislocalization. (A) HEK293A WT cells were transfected with EGFP-VPS4A E228Q ...
Figure 5.
Figure 5. PMC
NEDD4 regulates TDP-43 turnover, toxicity, and ubiquitination. (A) HEK-TDP-43-GFP cells were transfected with siRNAs targeting NEDD4 or noncoding con...
Figure S2.
Figure S2. PMC
HEK293A cells were transfected with HA-ubiquitin (pRB506) or both HA-Ub and NEDD4-mCherry (pRB334) and grown for 2 days before TDP-43 was immunoprecip...
Figure S3.
Figure S3. PMC
Endogenous TDP-43 and VPS4A interact. TDP-43 was immunoprecipitated in HEK293A cells in the presence or absence of CHQ treatment and/or NEDD4 knockdo...
Figure 6.
Figure 6. PMC
NEDD4 knockdown stabilizes TDP-43 in iNeurons. (A) Schematic of optical pulse labeling strategy for measuring TDP-43-Dendra2 half-life. (B) NEDD4 k...
Figure 7.
Figure 7. PMC
Mild TDP-43 overexpression causes accumulation of giant Rab7-positive vesicles. (A) HEK293A WT, HEK-TDP-43-GFP, and HEK-TDP-35-GFP cells were grown i...
Figure S4.
Figure S4. PMC
Giant Rab7 vesicular structures exhibit CD63 colocalization and CHQ-sensitive intraluminal CD63 bodies, suggesting an endolysosomal origin. (A) HEK29...
Figure 8.
Figure 8. PMC
Giant Rab7-positive vesicles are proteolytically active compartments. (A) HEK-TDP-43-GFP cells were grown in media containing solvent control (DMSO) ...
Figure S5.
Figure S5. PMC
Giant Rab7-positive vesicles are proteolytically active compartments. (A) HEK-TDP-35-GFP cells were grown in media containing solvent control (DMSO; ...
Figure 9.
Figure 9. PMC
Potential model of Rsp5/NEDD4 and ESCRT-dependent clearance of cytoplasmic TDP-43. We speculate that TDP-43 is subject to K63 polyubiquitination by R...